In this video, Shikha Saxena, MD, attending physician of the division of pulmonary and sleep medicine at the Children's ...

APG808 was well-tolerated and there were no severe adverse events. Credit: Explode via Shutterstock. At the 2025 European Respiratory Society (ERS) International Congress takig place in Amsterdam, the ...

Blood eosinophil count and fractional exhaled nitric oxide (FeNO) play an important role in selecting biological therapies for severe asthma. This analysis of patient-level data pooled across 22 ...

ATS 2024, San Diego – Only 14.5 percent of adult patients with moderate or severe asthma are prescribed the recommended SMART combination inhaler regimen and over 40 percent of academic pulmonary and ...

Posters presented at ACAAI 2023 Annual Scientific Congress examined dupilumab use in children with moderate-to-severe asthma and in the presence of elevated type 2 biomarkers. Two posters presented at ...

In a new clinical practice guideline, recommendations are presented to optimize the use of biologic agents for severe asthma in adults.

Treatment with high and low doses of rilzabrutinib resulted in 36% and 25% relative risk reduction in loss of asthma control events. Significant and clinically meaningful improvements in asthma ...

Children with moderate-to-severe asthma continue to have disease complications despite the receipt of standard-of-care therapy. The monoclonal antibody dupilumab has been approved for the treatment of ...

Rapid Rx Quiz: Severe Asthma Treatment Are you up-to-date on the latest research on severe asthma treatment, including effective biologics and factors associated with higher asthma biologic adherence?

The 2012 GLI race-specific equation failed to detect reduced lung function in 39% of Black children participating in three large cohorts. The 2022 GLI race-neutral equation identified two- to ...

In the trial, zumilokibart demonstrated: The only treatment-emergent adverse event (TEAE) observed in more than one patient was gastroesophageal reflux disease (GERD; 2 patients). There were no Grade ...